BRIDGEWAY CAPITAL MANAGEMENT, LLC

Position in AMRX — Amneal Pharmaceuticals, Inc.

CIK 1107261 HOUSTON, TX

Back to AMRX Full portfolio

Position in AMRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,323,161

-$81,096 QoQ

Shares Held

106,449

-4.5% QoQ

Ownership

0.033%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in AMRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

BRIDGEWAY CAPITAL MANAGEMENT, LLC holds $35,934,652 across 16 Drug Manufacturers - Specialty & Generic names. AMRX ranks #7 (3.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PCRX	Pacira BioSciences, Inc.	411,373	$9,297,029
2	PRGO	PERRIGO Co plc	815,347	$8,756,826
3	AMPH	Amphastar Pharmaceuticals, Inc.	330,457	$6,473,652
4	SUPN	Supernus Pharmaceuticals, Inc.	48,000	$2,481,120
5	UTHR	UNITED THERAPEUTICS Corp	2,620	$1,553,607
6	IRWD	Ironwood Pharmaceuticals Inc	440,493	$1,546,130
7	AMRX	Amneal Pharmaceuticals, Inc. This page	106,449	$1,323,161
8	INDV	Indivior Pharmaceuticals, Inc.	35,000	$1,066,800

All Filings in AMRX

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,323,161	106,449	-4.5%	Shares	Sole	2026-05-15
2025-12-31	$1,404,257	111,449	+34.0%	Shares	Sole	2026-02-17
2021-09-30	$444,288	83,200	0.0%	Shares	Sole	2021-11-15
2021-06-30	$425,984	83,200	-13.0%	Shares	Sole	2021-08-16
2021-03-31	$643,388	95,600	-66.1%	Shares	Sole	2021-05-17
2020-12-31	$1,290,568	282,400	+7.0%	Shares	Sole	2021-02-16
2020-09-30	$1,024,320	264,000	+7.5%	Shares	Sole	2020-11-16
2020-06-30	$1,168,580	245,500	—	Shares	Sole	2020-08-31
No filing history on record for this holder in this stock.